Tower Research Capital (TRC)’s Odyssey Therapeutics ODTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ODTX
Tower Research Capital (TRC)'s ODTX Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Odyssey Therapeutics (ODTX) stake by 488% in Q3 2026, buying an estimated $20K and bringing the position to 1,134 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3657.
Tower Research Capital (TRC) first reported a position in ODTX in Q2 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.
- Tower Research Capital (TRC) held 1,134 shares of Odyssey Therapeutics worth $25.2K as of Q3 2026.
- Tower Research Capital (TRC) bought 941 Odyssey Therapeutics shares in Q3 2026, an estimated $20K.
- Odyssey Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3657 holding.
- Tower Research Capital (TRC) first reported a position in Odyssey Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 74 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.